Delivery Order SPE2DB20D2104-SPE2DB25FMVWC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count supply) with a ceiling value of $51,539.65. This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded a $27,998.28 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 24 mg-26 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a $15,099.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for 4,565,916,350 units of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 180S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and...
- The Defense Logistics Agency awarded a $5,921.84 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 180 tablets of Entresto, a medication used to treat heart failure. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania within the period of performance between June 30, 2023 and July 3, 2023. The firm fixed price contract was awarded under an existing Amerisourcebergen blanket purchase...
- This is a $15,816.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Entresto 24 mg-26 mg tablets, a medication used to treat cardiovascular conditions. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the Department of Defense with Entresto 49 mg-51 mg tablets. The contract, valued at $15,060.89, has a period of performance through March 19, 2024. Amerisourcebergen is the prime contractor and there is no set-aside designation for this award. In addition to this specific delivery order,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $41,847.64 contract is for the supply of Entresto 24 mg-26 mg tablets in 180-count bottles, with a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $11,067.27 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60-count Entresto 97 mg-103 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 97 mg-103 mg tablets (60-count units) with a ceiling value of $2,242.17. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 21, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical vendor...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVWCDelivery Order
The Defense Logistics Agency awarded a $4,198.26 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 21, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. Entresto is a combination medication used primarily for heart failure treatment, reflecting the critical pharmaceutical support that AmerisourceBergen provides to the federal healthcare supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's competitively awarded contracts with the Defense Logistics Agency demonstrate its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, serving defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/18/25 |